Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$999K Buy
8,956
+60
+0.7% +$6.93K 0.36% 69
2025
Q4
$1.04M Buy
8,896
+376
+4% +$35.3K 0.4% 69
2025
Q3
$766K Hold
8,520
0.33% 74
2025
Q2
$682K Sell
8,520
-295
-3% -$23.4K 0.32% 79
2025
Q1
$686K Sell
8,815
-6,899
-44% -$644K 0.36% 73
2024
Q4
$1.56M Buy
+15,714
New +$1.62M 0.61% 49

Other funds holding MRK

Compass Capital Corp's MRK Position: Q1 2026 in Review

Compass Capital Corp increased its Merck (MRK) stake by 0.67% in Q1 2026, buying an estimated $6.93K and bringing the position to 8,956 shares worth $999K. The position accounts for 0.36% of the portfolio, ranked #69.

Compass Capital Corp first reported a position in MRK in Q4 2024 and has held it in 6 quarters since. The position peaked at $1.56M in Q4 2024. 3,780 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • Compass Capital Corp held 8,956 shares of Merck worth $999K as of Q1 2026.
  • Compass Capital Corp bought 60 Merck shares in Q1 2026, an estimated $6.93K.
  • Merck made up 0.36% of Compass Capital Corp's portfolio in Q1 2026, its #69 holding.
  • Compass Capital Corp first reported a position in Merck in Q4 2024 and has held it in 6 quarters since.
  • Compass Capital Corp's Merck position peaked at $1.56M in Q4 2024.
  • 3,780 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Compass Capital Corp's 13F filing for Q1 2026, filed 8 May 2026.